Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD)

BACKGROUND: Three classes of inhaler medications are used to manage chronic obstructive pulmonary disease (COPD): long‐acting beta‐agonists (LABA), long‐acting muscarinic antagonists (LAMA), and inhaled corticosteroids (ICS). When two classes of medications are required, LAMA plus LABA (LAMA+LABA) a...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cochrane Database Syst Rev
Главные авторы: Horita, Nobuyuki, Goto, Atsushi, Shibata, Yuji, Ota, Erika, Nakashima, Kentaro, Nagai, Kenjiro, Kaneko, Takeshi
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley & Sons, Ltd 2017
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464543/
https://ncbi.nlm.nih.gov/pubmed/28185242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012066.pub2
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы